menu

Rapidly Progressive MS: A Case Study

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Rapidly Progressive MS: A Case Study

Join Dr. Jiwon Oh as she reviews a case study on a patient with progressive multiple sclerosis.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Join Dr. Jiwon Oh as she reviews a case study on a patient with progressive multiple sclerosis. Dr. Oh will guide you through the diagnosis, treatment and prognosis process with this particular patient and how MRI findings were used to guide the decision making process.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty: 

    Dr. Jiwon Oh
    Assistant Professor, Department of Medicine
    Scientist, Li Ka Shing Knowledge Institute of St. Michael’s Hospital
    Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital
    Toronto, Ontario

    Dr. Oh has disclosed consulting fees from Biogen, EMD Serono, Genzyme, Novartis, Roche and Teva.

    Reviewers/Planners/Authors: 

    • Sean T. Barrett has nothing to disclose.
    • Carole Drexler, PhD, CHCP has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Joseph Theodore Phillips, MD, PhD has disclosed fees from Biogen, Genzyme and Merck Serono.
    • Ashley Pluta has nothing to disclose.
    • Lawrence Sherman, FACEHP, CHCP has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Integrate MRI findings and patients’ risk factors into MS prognosis to guide therapeutic decisions
    • Individualize MS therapy based on efficacy of the agents as well as patient’s presentation, preference and risk for adverse events
    • Examine the role of emerging agents in the management of RRMS
  • Target Audience

    This activity is designed to meet the educational needs of practicing neurologists, and other healthcare professionals that treat patients with multiple sclerosis.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 CreditsTM to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu.

  • Commercial Support

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and TOPEC Global. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Global Neurology Academy you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.